[Taodi-KY] Board resolution not to proceed with the private placement of securities approved at the 2025 Annual General Meeting
Taodi-KY's board of directors has decided not to proceed with the private placement of up to 10 million shares, originally approved in 2025, due to capital market conditions.
📋 Article Processing Timeline
- 📰 Published: May 15, 2026 at 09:00
- 🔍 Collected: May 16, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 16, 2026 at 09:21 (1h 21m after Collected)
1. Date of the board of directors resolution for the change: 2026/05/15
2. Originally planned effective date of registration: Not applicable
3. Date of supplementary issuance: Not applicable
4. Reason for change: The company's Annual General Meeting on June 26, 2025, authorized the board to issue up to 10,000,000 common shares via private placement in one or multiple tranches, depending on market conditions and specific investors. This authorization will expire on June 25, 2026. Considering current capital market conditions, the board plans not to proceed with the aforementioned private placement.
5. Funding plans before and after all previous changes: Not applicable
6. Expected execution progress: Not applicable
7. Expected completion date: Not applicable
8. Expected possible benefits: Not applicable
9. Difference from original expected benefits: Not applicable
10. Impact of this change on shareholder equity: Not applicable
11. Summary of the original lead underwriter's evaluation opinion: Not applicable
12. Other matters to be specified: None
2. Originally planned effective date of registration: Not applicable
3. Date of supplementary issuance: Not applicable
4. Reason for change: The company's Annual General Meeting on June 26, 2025, authorized the board to issue up to 10,000,000 common shares via private placement in one or multiple tranches, depending on market conditions and specific investors. This authorization will expire on June 25, 2026. Considering current capital market conditions, the board plans not to proceed with the aforementioned private placement.
5. Funding plans before and after all previous changes: Not applicable
6. Expected execution progress: Not applicable
7. Expected completion date: Not applicable
8. Expected possible benefits: Not applicable
9. Difference from original expected benefits: Not applicable
10. Impact of this change on shareholder equity: Not applicable
11. Summary of the original lead underwriter's evaluation opinion: Not applicable
12. Other matters to be specified: None